News | CT Angiography (CTA) | July 20, 2020

Canon Introduces New Aquilion One Genesis SP Cardiac CT Scanner

Solution powered by artificial intelligence and offers innovative cardiac image capabilities 

The new Aquilion One Genesis SP cardiac CT system uses artificial intelligence to help reconstruct low dose cardiac CT images. #SCCT2020

The new Aquilion One Genesis SP cardiac CT system uses artificial intelligence to help reconstruct low dose cardiac CT images.

July 20, 2020 – To meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA is introducing a new configuration of the Aquilion One / Genesis Edition – the Aquilion One / Genesis SP. The vendor said this is a complete cardiac CT solution that is designed for the evolving needs of structural and coronary imaging, enabling consistent, high-quality studies through its artificial intelligence (AI)-powered, wide-area CT.

The Canon Aquilion One Genesis SP cardiac CT scanner. #SCCT2020The Aquilion One / Genesis SP enhances Canon Medical’s suite of collaborative imaging tools which deliver clarity and confidence across the patient care cycle. Collaborative imaging provides a complete, integrated solution that helps medical practitioners address cardiovascular disease at every stage in the process, from evaluation to treatment, offering a wide range of features for complete cardiac care. These features include: 
   • Improved diagnostic confidence across patients with one-beat, whole-heart acquisition and advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR), which enables clinicians to obtain sharp, clear and distinct images. 
   • Enhanced workflow capabilities because of automated tools from acquisition through analysis such as SURECardio and Vitrea advanced visualization, which can help clinicians manage their new increase in patient volume, and also deliver proven consistency in high image quality. 
   • A lower total cost of ownership with a small footprint (204 square feet) that can fit into most existing CT rooms, unique scalability to fit varying technology needs and power save mode improvements that enable the Aquilion One Genesis / SP to require less cost to operate.
   • Patient-centric enhancements to help improve safety, comfort and access, including a wide bore (78 cm) and wide (47 cm) and low (33 cm) couch.

“Due to expanding applications of CT for structural heart procedures and coronary imaging, healthcare providers are growing their cardiac CT programs. At Canon Medical, we are committed to providing technologies that help clinicians keep pace with these evolving clinical pathways,” said Erin Angel, managing director, CT business unit, Canon Medical Systems USA Inc. “Canon Medical’s CT product line, including the Aquilion One / Genesis SP, is designed to offer complete cardiac capabilities. The platform was designed to be intuitive, making the acquisition of high quality images easy and reliable across the full spectrum of patients and clinical scenarios.”

Canon Medical is showcased the new CT system and its full suite of icardiac capabilities at the Society of Cardiac Computed Tomography (SCCT) 2020 virtual annual meeting. People can visit Canon's virtual booth at https://us.medical.canon/go/PR_7-2020_GENESIS_SP

For more information: https://us.medical.canon

Related Content

An example of a body composition analysis of an abdominal CT slice with the subcutaneous fat in green, skeletal muscle red and visceral fat in yellow. This was automatically identified and analyzed via a deep learning algorithm to assess the risk for heart attack and stroke in more than 12,000 patients. #RSNA2020 #RSNA20 #RSNA

An example of a body composition analysis of an abdominal CT slice with the subcutaneous fat in green, skeletal muscle red and visceral fat in yellow. This was automatically identified and analyzed via a deep learning algorithm to assess the risk for heart attack and stroke in more than 12,000 patients.

Feature | Artificial Intelligence | December 02, 2020
December 2, 2020 – Automated deep learning analysis of abdominal...
The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

News | Artificial Intelligence | November 24, 2020
November 24, 2020 — The U.S.
Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS.

Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS. 

News | Artificial Intelligence | November 12, 2020
November 12, 2020 – Konica Minolta Healthcare Americas Inc. and DiA Imaging Analysis Ltd.
The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

Feature | Artificial Intelligence | September 29, 2020 | Joe Fornadel, J.D., and Wes Moran, J.D.
The number of Federal Drug Administration (FDA)-approved AI-based algorithms is significant and has grown at a steady
Selfied might be used with AI to identify patients with heart disease. Getty Images

Getty Images

News | Artificial Intelligence | August 24, 2020
August 24, 2020 — Sending a photo selfie to the doctor could be a cheap and simple way of detecting heart disease usi
aption Health a leader in medical AI technology, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an updated version of Caption Interpretation, which uses artificial intelligence (AI) to enable clinicians to obtain quick, easy and accurate measurements of cardiac ejection fraction (EF) at the point of care.

Caption Health a leader in medical AI technology, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an updated version of Caption Interpretation, which uses artificial intelligence (AI) to enable clinicians to obtain quick, easy and accurate measurements of cardiac ejection fraction (EF) at the point of care.

News | Artificial Intelligence | August 19, 2020
August 19, 2020 — Caption Health a leader in medical AI technology, has received U.S.
In February 2020, the U.S. Food and Drug Administration (FDA) cleared artificial intelligence software to assist in the acquisition of cardiac ultrasound images. The Caption Guidance software from Caption Health is an accessory to compatible diagnostic ultrasound systems and uses artificial intelligence to help the user capture images of a patient’s heart that are of acceptable diagnostic quality. It is aimed at point of care ultrasound (POCUS) exams, where users may not be regular sonographers.

In February 2020, the U.S. Food and Drug Administration (FDA) cleared artificial intelligence software to assist in the acquisition of cardiac ultrasound images. The Caption Guidance software from Caption Health is an accessory to compatible diagnostic ultrasound systems and uses artificial intelligence to help the user capture images of a patient’s heart that are of acceptable diagnostic quality. It is aimed at point of care ultrasound (POCUS) exams, where users may not be regular sonographers.

Feature | Artificial Intelligence | August 18, 2020 | Dave Fornell, Editor
The No.